Sarfez’s Soaanz Receives the US FDA’s Approval for the Treatment of Heart Failure and Renal Disease

Shots:

• The US FDA has approved Soaan for the treatment of heart failure & renal disease. The therapy offers a new treatment option for heart failure patients who experience persistent edema, swelling in the lower limbs & abdomen despite a loop diuretic therapy
• The approved drug also provides an alternative treatment for both chronic kidney disease & heart failure patients who skip loop diuretic treatment due to excessive urination
• Soaanz (PO, qd, tablet) is an improved formulation of the loop diuretic torsemide that provides a longer duration of peak effect without causing excessive urination. The company plans to launch the therapy in the next few mos.

Click here to­ read full press release/ article | Ref: Sarfez | Image: Sarfez